Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)

Author： van Rijswijk R.E.N.   Vermorken J.B.   Reed N.   Favalli G.   Mendiola C.   Zanaboni F.   Mangili G.   Vergote I.   Guastalla J.P.   ten Bokkel Huinink W.W.   Lacave A.J.   Bonnefoi H.   Tumulo S.   Rietbroek R.   Teodorovic I.   Coens C.   Pecorelli S.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.39, Iss.4, 2003-03, pp. : 481-487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study

By Wagenaar H.C.   Pecorelli S.   Mangioni C.   van der Burg M.E.L.   Rotmensz N.   Anastasopoulou A.   Zola P.   Veenhof C.H.N.   Lacave A.J.   Neijt J.P.   van Oosterom A.T.   Einhorn N.   Vermorken J.B.  

European Journal of Cancer, Vol. 37, Iss. 13, 2001-09 ,pp. : 1624-1628

Elsevier

Access to resources Recommend Favorite

Fotemustine in Patients with Advanced Gastric Cancer, a Phase II Trial From the EORTC-GITCCG (European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cancer Cooperative Group)

By the EORTC-GITCCG   Rougier P.   Van Pottelsberghe C.   Kok T.   Paillot B.   Wagener T.   De Greve J.   Fabri M.C.   Gerard B.   Van Glabbeke M.   Bleiberg H.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1432-1433

Elsevier

Access to resources Recommend Favorite

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

By Coudert B.   Anthoney A.   Fiedler W.   Droz J.P.   Dieras V.   Borner M.   Smyth J.F.   Morant R.   de Vries M.J.   Roelvink M.   Fumoleau P.  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2194-2198

Elsevier

Access to resources Recommend Favorite

Phase II Study of Weekly 4'-Epidoxorubicin in Patients with Metastatic Adenocarcinoma of the Cervix: an EORTC Gynaecological Cancer Cooperative Group Study

By van der Burg M.E.L.   Bolis G.   Bakker P.J.M.   Curran D.   Sahmoud T.   Vermorken J.B.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1513-1515

Elsevier

Access to resources Recommend Favorite

Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with -interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial

By Wagener D.J.T.   Wils J.A.   Kok T.C.   Planting A.   Couvreur M.L.   Baron B.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 648-653

Elsevier

Access to resources Recommend Favorite